What are the major opportunities in the Postherpetic Neuralgia PHN market? What are the strategies for the Postherpetic Neuralgia PHN market?

For detailed insights on the major opportunities and strategies in the Postherpetic Neuralgia PHN market, Read More

How does the Postherpetic Neuralgia PHN market relate to the overall economy and other similar markets?

For detailed insights on Postherpetic Neuralgia PHN's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Postherpetic Neuralgia PHN market growth? SWOT analysis of the Postherpetic Neuralgia PHN market.

For detailed insights on the key dynamics influencing the Postherpetic Neuralgia PHN market growth and SWOT analysis of the Postherpetic Neuralgia PHN industry, Read More

Postherpetic Neuralgia (PHN) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Postherpetic Neuralgia (PHN) Market Report 2026

Name: Postherpetic Neuralgia (PHN) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Patches, Drugs, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End Users (Hospitals, Clinics, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Postherpetic Neuralgia (PHN) Market Overview

• Postherpetic Neuralgia (PHN) market size has reached to $0.77 billion in 2025

• Expected to grow to $1.06 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%

• Growth Driver: Rising Prevalence Of Chronic Pain Conditions Propelling The Growth Of The Market Due To Increasing Demand For Chronic Pain Management And Expanding Ageing Population

• Market Trend: Regulatory Approvals Driving Growth In The Market Due To Expanded Access To Effective Treatments

• North America was the largest region in 2025.

What Is Covered Under Postherpetic Neuralgia (PHN) Market?

Postherpetic neuralgia (PHN) is a chronic nerve pain condition that occurs as a complication following an outbreak of herpes zoster (shingles). It is characterized by persistent, often severe pain in the area where the shingles rash appeared, lasting for months or even years after the rash has healed. Postherpetic neuralgia (PHN) results from nerve damage caused by the varicella-zoster virus reactivation and is the most common complication of shingles, especially in older adults.

The main types of postherpetic neuralgia (PHN) are patches, drugs, and opioids. Patches refer to transdermal drug delivery systems that are applied directly to the skin to provide a controlled release of medication into the bloodstream. It distributed through hospital pharmacies, retail pharmacies, and online pharmacies, catering to end users, such as hospitals, clinics, ambulatory surgical centers, and others.

Postherpetic Neuralgia (PHN) Market Global Report 2026 Market Report bar graph

What Is The Postherpetic Neuralgia (PHN) Market Size and Share 2026?

The postherpetic neuralgia (phn) market size has grown strongly in recent years. It will grow from $0.77 billion in 2025 to $0.82 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing incidence of herpes zoster infections, limited treatment options for neuropathic pain, reliance on opioid-based pain management, growing elderly population, gradual expansion of hospital pain management services.

What Is The Postherpetic Neuralgia (PHN) Market Growth Forecast?

The postherpetic neuralgia (phn) market size is expected to see strong growth in the next few years. It will grow to $1.06 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of targeted neuropathic pain therapies, rising adoption of biologic and branded drugs, growth of online pharmacy distribution channels, increasing focus on patient-centric pain management, expansion of outpatient and ambulatory care facilities. Major trends in the forecast period include rising prevalence of shingles in aging population, increasing adoption of non-opioid pain management therapies, growing use of transdermal and topical pain relief solutions, higher demand for long-term chronic pain management, improved awareness and early diagnosis of phn.

Book your 30 minutes free consultation with our research experts

Global Postherpetic Neuralgia (PHN) Market Segmentation

1) By Type: Patches, Drugs, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End Users: Hospitals, Clinics, Other End Users

Subsegments:

1) By Patches: Transdermal Drug Delivery Patches, Analgesic Patches

2) By Drugs: Prescription Drugs, Over-The-Counter (OTC) Drugs, Generic Drugs, Branded Drugs, Biologic Drugs

3) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids, Opioid Analgesics, Opioid Antagonists

What Is The Driver Of The Postherpetic Neuralgia (PHN) Market?

The increasing prevalence of chronic pain conditions is expected to propel the growth of the postherpetic neuralgia (PHN) market going forward. Chronic pain refers to persistent or recurring pain lasting more than 3 months, often continuing beyond the usual course of an illness or injury and affecting a person's daily functioning and quality of life. The prevalence of chronic pain conditions is due to the aging population, as older adults are more prone to degenerative diseases like arthritis and neuropathy that lead to persistent pain. Postherpetic neuralgia is helpful for chronic pain research as it provides a clear model to study nerve-related pain mechanisms and evaluate long-term treatment strategies. For instance, in January 2024, according to a report published by the Office for Health Improvement and Disparities, a UK-based government department, around 18.4% of people aged 16 and over reported having a long-term musculoskeletal (MSK) condition in 2023, marking a rise from 17.6% in 2022. Therefore, the increasing prevalence of chronic pain conditions is driving the growth of the postherpetic neuralgia (PHN) industry.

Key Players In The Global Postherpetic Neuralgia (PHN) Market

Major companies operating in the postherpetic neuralgia (phn) market are Pfizer Inc., Merck & Co. Inc., Novartis AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Limited, Mylan N.V., Mallinckrodt plc, Merz Therapeutics GmbH, Acorda Therapeutics Inc., Scilex Holding Company, Elorac Inc., Oxford Cannabinoid Technologies Holdings plc, Teikoku Pharma USA Inc., Haisco Pharmaceutical Group Co. Ltd., Eli Lilly and Company, Johnson & Johnson, AbbVie Inc., AstraZeneca plc, Sanofi S.A., Grünenthal GmbH, Endo International plc, Purdue Pharma L.P., Hikma Pharmaceuticals plc, Cipla Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd.

Global Postherpetic Neuralgia (PHN) Market Trends and Insights

Major companies operating in the postherpetic neuralgia (PHN) market are focusing on obtaining regulatory approvals to expand their product portfolios, gain competitive advantage, and meet the significant unmet clinical need for more effective and tolerable treatments. Regulatory approvals refer to the official permissions granted by government health authorities allowing a drug or treatment to be legally marketed and used for a specific medical condition. For instance, in February 2023, Zydus Lifesciences Ltd., an India-based pharmaceutical company, received final the United States Food and Drug Administration approval to manufacture and market once-daily generic Gabapentin Tablets in 300 mg and 600 mg strengths, indicated for the management of postherpetic neuralgia (PHN). The gabapentin tablets are intended for treating PHN, a type of neuropathic pain resulting from nerve damage caused by the reactivation of the varicella-zoster virus. For PHN, the typical dosing starts at 300 mg on the first day, increases to 600 mg (300 mg twice daily) on the second day, and 900 mg (300 mg three times daily) on the third day, with titration up to a maximum of 1800 mg per day (600 mg three times daily) as needed for pain relief.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Postherpetic Neuralgia (PHN) Market?

In September 2023, Adalvo Limited, a Malta-based pharmaceutical company focusing primarily on selling services to companies, partnered with Lotus Pharmaceutical Co. Ltd. to launch Gabapentin ER tablets in South Korea. This collaboration aims to enhance patient access to innovative and effective treatments by introducing Gabapentin ER in South Korea, strengthening their presence in the neurology market, and expanding their portfolios with high-value pharmaceutical products. Lotus Pharmaceutical Co., Ltd. is a Taiwan-based pharmaceutical company that manufactures medication for postherpetic neuralgia (PHN).

Regional Insights

North America was the largest region in the postherpetic neuralgia (PHN) market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Postherpetic Neuralgia (PHN) Market?

The postherpetic neuralgia (PHN) market includes revenues earned by entities by providing services such as medical consultation, pain management services, topical treatment application, physical therapy and nerve block or injections. The market value includes the value of related goods sold by the service provider or included within the service offering. The postherpetic neuralgia (PHN) market consists of sales of anticonvulsants, amitriptyline, tramadol, oxycodone, and nortriptyline. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Postherpetic Neuralgia (PHN) Market Report 2026?

The postherpetic neuralgia (phn) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the postherpetic neuralgia (phn) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Postherpetic Neuralgia (PHN) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$0.82 billion
Revenue Forecast In 2035	$1.06 billion
Growth Rate	CAGR of 6.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Distribution Channel, End Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Merck & Co. Inc., Novartis AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Limited, Mylan N.V., Mallinckrodt plc, Merz Therapeutics GmbH, Ac
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Postherpetic Neuralgia (PHN) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Postherpetic Neuralgia (PHN) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Postherpetic Neuralgia (PHN) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Postherpetic Neuralgia (PHN) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.2. Major Trends

4.2.1 Rising Prevalence Of Shingles In Aging Population

4.2.2 Increasing Adoption Of Non-Opioid Pain Management Therapies

4.2.3 Growing Use Of Transdermal And Topical Pain Relief Solutions

4.2.4 Higher Demand For Long-Term Chronic Pain Management

4.2.5 Improved Awareness And Early Diagnosis Of Phn

5. Postherpetic Neuralgia (PHN) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Ambulatory Surgical Centers

5.4 Pain Management Centers

5.5 Home Healthcare Providers

6. Postherpetic Neuralgia (PHN) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Postherpetic Neuralgia (PHN) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Postherpetic Neuralgia (PHN) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Postherpetic Neuralgia (PHN) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Postherpetic Neuralgia (PHN) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Postherpetic Neuralgia (PHN) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Postherpetic Neuralgia (PHN) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Postherpetic Neuralgia (PHN) Market Segmentation

9.1. Global Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Patches, Drugs, Opioids

9.2. Global Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.3. Global Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Other End Users

9.4. Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Transdermal Drug Delivery Patches, Analgesic Patches

9.5. Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prescription Drugs, Over-The-Counter (OTC) Drugs, Generic Drugs, Branded Drugs, Biologic Drugs

9.6. Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids, Opioid Analgesics, Opioid Antagonists

10. Postherpetic Neuralgia (PHN) Market Regional And Country Analysis

10.1. Global Postherpetic Neuralgia (PHN) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Postherpetic Neuralgia (PHN) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Postherpetic Neuralgia (PHN) Market

11.1. Asia-Pacific Postherpetic Neuralgia (PHN) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Postherpetic Neuralgia (PHN) Market

12.1. China Postherpetic Neuralgia (PHN) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Postherpetic Neuralgia (PHN) Market

13.1. India Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Postherpetic Neuralgia (PHN) Market

14.1. Japan Postherpetic Neuralgia (PHN) Market Overview

14.2. Japan Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Postherpetic Neuralgia (PHN) Market

15.1. Australia Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Postherpetic Neuralgia (PHN) Market

16.1. Indonesia Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Postherpetic Neuralgia (PHN) Market

17.1. South Korea Postherpetic Neuralgia (PHN) Market Overview

17.2. South Korea Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Postherpetic Neuralgia (PHN) Market

18.1. Taiwan Postherpetic Neuralgia (PHN) Market Overview

18.2. Taiwan Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Postherpetic Neuralgia (PHN) Market

19.1. South East Asia Postherpetic Neuralgia (PHN) Market Overview

19.2. South East Asia Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Postherpetic Neuralgia (PHN) Market

20.1. Western Europe Postherpetic Neuralgia (PHN) Market Overview

20.2. Western Europe Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Postherpetic Neuralgia (PHN) Market

21.1. UK Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Postherpetic Neuralgia (PHN) Market

22.1. Germany Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Postherpetic Neuralgia (PHN) Market

23.1. France Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Postherpetic Neuralgia (PHN) Market

24.1. Italy Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Postherpetic Neuralgia (PHN) Market

25.1. Spain Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Postherpetic Neuralgia (PHN) Market

26.1. Eastern Europe Postherpetic Neuralgia (PHN) Market Overview

26.2. Eastern Europe Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Postherpetic Neuralgia (PHN) Market

27.1. Russia Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Postherpetic Neuralgia (PHN) Market

28.1. North America Postherpetic Neuralgia (PHN) Market Overview

28.2. North America Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Postherpetic Neuralgia (PHN) Market

29.1. USA Postherpetic Neuralgia (PHN) Market Overview

29.2. USA Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Postherpetic Neuralgia (PHN) Market

30.1. Canada Postherpetic Neuralgia (PHN) Market Overview

30.2. Canada Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Postherpetic Neuralgia (PHN) Market

31.1. South America Postherpetic Neuralgia (PHN) Market Overview

31.2. South America Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Postherpetic Neuralgia (PHN) Market

32.1. Brazil Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Postherpetic Neuralgia (PHN) Market

33.1. Middle East Postherpetic Neuralgia (PHN) Market Overview

33.2. Middle East Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Postherpetic Neuralgia (PHN) Market

34.1. Africa Postherpetic Neuralgia (PHN) Market Overview

34.2. Africa Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Postherpetic Neuralgia (PHN) Market Regulatory and Investment Landscape

36. Postherpetic Neuralgia (PHN) Market Competitive Landscape And Company Profiles

36.1. Postherpetic Neuralgia (PHN) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Postherpetic Neuralgia (PHN) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Postherpetic Neuralgia (PHN) Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

37. Postherpetic Neuralgia (PHN) Market Other Major And Innovative Companies

Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Limited, Mylan N.V., Mallinckrodt plc, Merz Therapeutics GmbH, Acorda Therapeutics Inc., Scilex Holding Company, Elorac Inc., Oxford Cannabinoid Technologies Holdings plc, Teikoku Pharma USA Inc., Haisco Pharmaceutical Group Co. Ltd., Eli Lilly and Company, Johnson & Johnson, AbbVie Inc.

38. Global Postherpetic Neuralgia (PHN) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Postherpetic Neuralgia (PHN) Market

40. Postherpetic Neuralgia (PHN) Market High Potential Countries, Segments and Strategies

40.1 Postherpetic Neuralgia (PHN) Market In 2030 - Countries Offering Most New Opportunities

40.2 Postherpetic Neuralgia (PHN) Market In 2030 - Segments Offering Most New Opportunities

40.3 Postherpetic Neuralgia (PHN) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Postherpetic Neuralgia (PHN) Market, Overview Of Key Products - Product Examples

Table 2: Global Postherpetic Neuralgia (PHN) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Postherpetic Neuralgia (PHN) Market, Supply Chain Analysis

Table 4: Global Postherpetic Neuralgia (PHN) Market, Major Raw Material Providers

Table 5: Global Postherpetic Neuralgia (PHN) Market, Major Resource Providers

Table 6: Global Postherpetic Neuralgia (PHN) Market, Major Manufacturers (Suppliers)

Table 7: Global Postherpetic Neuralgia (PHN) Market, Major Distributors And Channel Partners

Table 8: Global Postherpetic Neuralgia (PHN) Market, Key Technologies & Future Trends

Table 9: Global Postherpetic Neuralgia (PHN) Market, Major Trends

Table 10: Global Postherpetic Neuralgia (PHN) Market, Major End Users

Table 11: Global Postherpetic Neuralgia (PHN) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Postherpetic Neuralgia (PHN) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Postherpetic Neuralgia (PHN) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Postherpetic Neuralgia (PHN) Market - TAM, US$ Billion, 2025

Table 15: Global Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Postherpetic Neuralgia (PHN) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Postherpetic Neuralgia (PHN) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Postherpetic Neuralgia (PHN) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Postherpetic Neuralgia (PHN) Market - Company Scoring Matrix

Table 97: Pfizer Inc. Financial Performance

Table 98: Merck & Co. Inc. Financial Performance

Table 99: Novartis AG Financial Performance

Table 100: GlaxoSmithKline plc Financial Performance

Table 101: Teva Pharmaceutical Industries Limited Financial Performance

Table 102: Global Postherpetic Neuralgia (PHN) Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Postherpetic Neuralgia (PHN) Market, Competitive Dashboard

Table 104: Global Postherpetic Neuralgia (PHN) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Postherpetic Neuralgia (PHN) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 106: Global, Postherpetic Neuralgia (PHN) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Table 107: Global, Postherpetic Neuralgia (PHN) Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

List Of Figures

Figure 1: Global Postherpetic Neuralgia (PHN) Market, Overview Of Key Products - Product Examples

Figure 2: Global Postherpetic Neuralgia (PHN) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Postherpetic Neuralgia (PHN) Market, Supply Chain Analysis

Figure 4: Global Postherpetic Neuralgia (PHN) Market, Major Raw Material Providers

Figure 5: Global Postherpetic Neuralgia (PHN) Market, Major Resource Providers

Figure 6: Global Postherpetic Neuralgia (PHN) Market, Major Manufacturers (Suppliers)

Figure 7: Global Postherpetic Neuralgia (PHN) Market, Major Distributors And Channel Partners

Figure 8: Global Postherpetic Neuralgia (PHN) Market, Key Technologies & Future Trends

Figure 9: Global Postherpetic Neuralgia (PHN) Market, Major Trends

Figure 10: Global Postherpetic Neuralgia (PHN) Market, Major End Users

Figure 11: Global Postherpetic Neuralgia (PHN) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Postherpetic Neuralgia (PHN) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Postherpetic Neuralgia (PHN) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Postherpetic Neuralgia (PHN) Market - TAM, US$ Billion, 2025

Figure 15: Global Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Postherpetic Neuralgia (PHN) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Postherpetic Neuralgia (PHN) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Postherpetic Neuralgia (PHN) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Postherpetic Neuralgia (PHN) Market - Company Scoring Matrix

Figure 97: Pfizer Inc. Financial Performance

Figure 98: Merck & Co. Inc. Financial Performance

Figure 99: Novartis AG Financial Performance

Figure 100: GlaxoSmithKline plc Financial Performance

Figure 101: Teva Pharmaceutical Industries Limited Financial Performance

Figure 102: Global Postherpetic Neuralgia (PHN) Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Postherpetic Neuralgia (PHN) Market, Competitive Dashboard

Figure 104: Global Postherpetic Neuralgia (PHN) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Postherpetic Neuralgia (PHN) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 106: Global, Postherpetic Neuralgia (PHN) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Figure 107: Global, Postherpetic Neuralgia (PHN) Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Breast Implants Market Report 2026 - Global Outlook – By Type (Silicone Implant, Form-stable Implant, Saline Implant, Structured Saline Implant), By Procedure (Breast Augmentation, Breast Reconstruction), By End User (Ho...

Ocular Implants Market Report 2026 - Global Outlook – By Product (Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants), By Application (Cataract Surgery, Glaucoma Management And Surgery, Corneal Disor...

Bio-Implants Market Report 2026 - Global Outlook – By Type (Cardiovascular Implants, Dental Implants, Spinal Bio-Implants, Orthopedic Implants, Ophthalmic Implants, Other Types), By Material (Metallic, Ceramic, Polymer, ...

Microelectronic Medical Implants Market Report 2026 - Global Outlook – By Product (Neurostimulators, Drug Infusion Pumps, Pacemakers, Spinal Fusion Stimulators, Implantable Drug Pumps, Hearing Implants, Eye Implants, Ocu...

Hip Replacement Implants Market Report 2026 - Global Outlook – By Product Type (Femoral Reconstruction, Acetabular Reconstruction, Revision Hip Implants), By Component (Ace Tabular Cup Systems, Hip Stem Systems, Revision...

Dental Implants And Prosthetics Market Report 2026 - Global Outlook – By Product Type (Dental Bridges, Dental Implants, Dental Crown, Abutment, Dentures), By Design (Tapered Dental Implants, Parallel-Walled Dental Implan...

Knee Implants Market Report 2026 - Global Outlook – By Product (Total Knee Replacement, Partial Knee Replacement, Revision Knee Replacement), By Material (Stainless Steel, Cobalt-Chromium Alloys, Titanium Alloys, Polyeth...

Frequently Asked Questions

How big is the Postherpetic Neuralgia (PHN) Market?

The Postherpetic Neuralgia (PHN) market was valued at $0.77 billion in 2025, increased to $0.82 billion in 2026, and is projected to reach $1.06 billion by 2030.

What is the Postherpetic Neuralgia (PHN) market growth?

The global Postherpetic Neuralgia (PHN) market is expected to grow at a CAGR of 6.5% from 2026 to 2035 to reach $1.06 billion by 2035.

Who are the key players in Postherpetic Neuralgia (PHN) market?

Some Key Players in the Postherpetic Neuralgia (PHN) market Include, Pfizer Inc., Merck & Co. Inc., Novartis AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Limited, Mylan N.V., Mallinckrodt plc, Merz Therapeutics GmbH, Acorda Therapeutics Inc., Scilex Holding Company, Elorac Inc., Oxford Cannabinoid Technologies Holdings plc, Teikoku Pharma USA Inc., Haisco Pharmaceutical Group Co. Ltd., Eli Lilly and Company, Johnson & Johnson, AbbVie Inc., AstraZeneca plc, Sanofi S.A., Grünenthal GmbH, Endo International plc, Purdue Pharma L.P., Hikma Pharmaceuticals plc, Cipla Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd. .

What is the anticipated growth trend for the Postherpetic Neuralgia (PHN) market?

Major trend in this market includes: Regulatory Approvals Driving Growth In The Market Due To Expanded Access To Effective Treatments. For further insights on this market. request a sample here

Which region has the most growth potential in the Postherpetic Neuralgia (PHN) market?

North America was the largest region in the postherpetic neuralgia (PHN) market in 2025. The regions covered in the postherpetic neuralgia (phn) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.